Literature DB >> 11228087

Refractory no-reflow successfully treated with local infusion of high-dose adenosine and verapamil--a case report.

W C Dillon1, D Hadian, M E Ritchie.   

Abstract

No-reflow is an unpredictable complication following percutaneous coronary intervention. No-reflow is associated with myocardial ischemia and infarction and increased mortality. A case of refractory no-reflow is described that was rapidly and successfully treated with multiple infusions of high doses of verapamil and adenosine applied directly at the site of no-reflow through a perfusion catheter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11228087     DOI: 10.1177/000331970105200208

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

1.  Coronary No-reflow Phenomenon.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-05

2.  Distal administration of very high doses of intracoronary adenosine for the treatment of resistant no-reflow.

Authors:  Mohammad-Reza Movahed; Gurpreet Baweja
Journal:  Exp Clin Cardiol       Date:  2008
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.